European Heart Journal
Semaglutide, independent of weight loss, attenuates cardiac and hepatic remodelling in experimental heart failure with preserved ejection fraction
Experiments in animalsInterventions
Papers by Sanjiv J. Shah
8 results
- Redox Biology
Combination of genetic eNOS deficiency and high-fat diet induces reproducible cardiometabolic HFpEF
Experiments in animalsMechanisms - AHA Scientific Sessions 2025 Abstract
Interplay Between Heart Failure Progression, New-Onset Diabetes, and Finerenone: A FINEARTS-HF Analysis
Trial in peopleInterventions
- AHA Scientific Sessions 2025 Abstract
Major Adverse Cardiovascular Events across the Spectrum of Cardio-Kidney-Metabolic Syndrome: A FINE-HEART Pooled Analysis
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Finerenone Reduces Sudden Death across the Spectrum of Cardio-Kidney-Metabolism: the FINE-HEART Pooled Analysis
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
Finerenone and liver fibrosis assessed by fibrosis-4 (FIB-4) index in patients with heart failure and mildly reduced or preserved ejection fraction: Results from the FINEARTS-HF trial
Trial in peopleInterventions - AHA Scientific Sessions 2025 Abstract
The ICAM1 p.K56M HFpEF Risk Variant and Measures of Adiposity
Study in peopleMechanisms